SK Bioscience Co (XKRX:302440) PB Ratio : 2.35 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), SK Bioscience Co's share price is ₩51700.00. SK Bioscience Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩22,017.24. Hence, SK Bioscience Co's PB Ratio of today is 2.35.

Good Sign:

SK Bioscience Co Ltd stock PB Ratio (=2.35) is close to 5-year low of 2.35

The historical rank and industry rank for SK Bioscience Co's PB Ratio or its related term are showing as below:

XKRX:302440' s PB Ratio Range Over the Past 10 Years
Min: 2.35 Med: 3.76 Max: 38.63
Current: 2.35

During the past 6 years, SK Bioscience Co's highest PB Ratio was 38.63. The lowest was 2.35. And the median was 3.76.

XKRX:302440's PB Ratio is ranked better than
53.32% of 1311 companies
in the Biotechnology industry
Industry Median: 2.55 vs XKRX:302440: 2.35

During the past 12 months, SK Bioscience Co's average Book Value Per Share Growth Rate was -2.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 72.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -2.90% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of SK Bioscience Co was 81.30% per year. The lowest was -42.40% per year. And the median was 72.60% per year.

Back to Basics: PB Ratio

SK Bioscience Co PB Ratio Historical Data

The historical data trend for SK Bioscience Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co PB Ratio Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

10.75

3.24

3.25

SK Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															3.20	3.57	3.02	3.25	2.78

Competitive Comparison of SK Bioscience Co's PB Ratio

For the Biotechnology subindustry, SK Bioscience Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SK Bioscience Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Bioscience Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where SK Bioscience Co's PB Ratio falls into.

SK Bioscience Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

SK Bioscience Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	51700.00	/	22017.24
	=	2.35

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

SK Bioscience Co (XKRX:302440) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

SK Bioscience Co PB Ratio Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co (XKRX:302440) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co (XKRX:302440) Headlines

No Headlines